Certara, Inc. (CERT)
After hours:
| Previous Close | 19.65 |
| Open | 19.85 |
| Bid | 7.77 x 900 |
| Ask | 22.50 x 800 |
| Day's Range | 19.01 - 20.16 |
| 52 Week Range | 16.17 - 45.48 |
| Volume | |
| Avg. Volume | 640,795 |
| Market Cap | 3.165B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 |
| Earnings Date | Aug 03, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25.00 |
- Motley Fool
Certara, Inc. (CERT) Q1 2022 Earnings Call Transcript
On the call from Certara, we have William Feehery, chief executive officer; and Andrew Schemick, chief financial officer. Earlier today, Certara released financial results for the quarter ended March 31st, 2022.
- Zacks
Certara, Inc. (CERT) Matches Q1 Earnings Estimates
Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 2.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Certara Reports First Quarter 2022 Financial Results
PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2022. First Quarter Highlights: Revenue was $81.6 million, compared to $66.7 million in the first quarter of 2021, representing growth of 22% over the first quarter of 2021. Excluding Pinnacle 21, revenue was $75.6 million, representing growth of 13% over the first quarter of 2021. Net income was $2.2 million,
